Insider · CIK 0001996353
Brian Patrick McNulty
Files at MIRA (MIRA PHARMACEUTICALS, INC.). First filing Dec 27, 2023, latest Aug 30, 2024.
In brief
Brian Patrick McNulty files SEC Form 4 as 10% owner at MIRA (MIRA PHARMACEUTICALS, INC.). Since Dec 27, 2023, Brian Patrick McNulty has reported 0 open-market buys worth $0 and 2 open-market sells worth $1.1M, the latest filed on Aug 30, 2024.
A track record needs three past buys with six months of prices behind them; Brian Patrick McNulty has 0, so none is measured yet.
The newest scored trade: sold $392k of MIRA on Aug 28, 2024, filed Aug 30, 2024, scored 28 (weak).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
MIRA: MIRA PHARMACEUTICALS, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 28Weak | MIRAsell MIRA PHARMACEUTICALS, INC. | $392k 200,000 shares | -7% | +217% from low-73% from high | |
| 33Weak | MIRAsell MIRA PHARMACEUTICALS, INC. | $726k 238,095 shares | -8% | +227% from low-37% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Sep 4, 2024 | MIRA MIRA Pharmaceuticals, Inc. | 10,000 0.07% of outstanding | $18k | Sep 4, 2024 | none |
Transactions
Every row this insider has filed, 23 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 28, 2024 | MIRA MIRA PHARMACEUTICALS, INC. | SOpen-market sale Common Stockindirect: By Trust | -200,000 | $1.96 | $392k | 2,540,270 | Aug 30, 2024 |
| Nov 20, 2023 | MIRA MIRA PHARMACEUTICALS, INC. | SOpen-market sale Common Stockindirect: By Trust | -13,367 | $5.07 | $68k | 2,845,951 | Dec 27, 2023 |
| Nov 21, 2023 | MIRA MIRA PHARMACEUTICALS, INC. | SOpen-market sale Common Stockindirect: By Trust | -2,500 | $5.00 | $13k | 2,843,451 | Dec 27, 2023 |
| Nov 27, 2023 | MIRA MIRA PHARMACEUTICALS, INC. | SOpen-market sale Common Stockindirect: By Trust | -3,213 | $4.00 | $13k | 2,840,238 | Dec 27, 2023 |
| Nov 28, 2023 | MIRA MIRA PHARMACEUTICALS, INC. | SOpen-market sale Common Stockindirect: By Trust | -121 | $4.00 | $484 | 2,840,117 | Dec 27, 2023 |
| Nov 29, 2023 | MIRA MIRA PHARMACEUTICALS, INC. | SOpen-market sale Common Stockindirect: By Trust | -3,699 | $3.98 | $15k | 2,836,418 | Dec 27, 2023 |
| Nov 30, 2023 | MIRA MIRA PHARMACEUTICALS, INC. | SOpen-market sale Common Stockindirect: By Trust | -2,421 | $3.77 | $9,136 | 2,833,997 | Dec 27, 2023 |
| Dec 4, 2023 | MIRA MIRA PHARMACEUTICALS, INC. | SOpen-market sale Common Stockindirect: By Trust | -30,665 | $3.98 | $122k | 2,803,332 | Dec 27, 2023 |
| Dec 6, 2023 | MIRA MIRA PHARMACEUTICALS, INC. | SOpen-market sale Common Stockindirect: By Trust | -13,867 | $2.95 | $41k | 2,789,465 | Dec 27, 2023 |
| Dec 7, 2023 | MIRA MIRA PHARMACEUTICALS, INC. | SOpen-market sale Common Stockindirect: By Trust | -16,666 | $1.89 | $32k | 2,772,799 | Dec 27, 2023 |
| Dec 8, 2023 | MIRA MIRA PHARMACEUTICALS, INC. | SOpen-market sale Common Stockindirect: By Trust | -9,526 | $1.61 | $15k | 2,763,273 | Dec 27, 2023 |
| Dec 11, 2023 | MIRA MIRA PHARMACEUTICALS, INC. | SOpen-market sale Common Stockindirect: By Trust | -23,003 | $1.55 | $36k | 2,740,270 | Dec 27, 2023 |
| Nov 20, 2023 | MIRA MIRA PHARMACEUTICALS, INC. | SOpen-market sale Common Stockindirect: By Trust | -13,366 | $5.07 | $68k | 765,681 | Dec 27, 2023 |
| Nov 21, 2023 | MIRA MIRA PHARMACEUTICALS, INC. | SOpen-market sale Common Stockindirect: By Trust | -2,500 | $5.00 | $13k | 763,181 | Dec 27, 2023 |
| Nov 27, 2023 | MIRA MIRA PHARMACEUTICALS, INC. | SOpen-market sale Common Stockindirect: By Trust | -3,212 | $4.00 | $13k | 759,969 | Dec 27, 2023 |
| Nov 28, 2023 | MIRA MIRA PHARMACEUTICALS, INC. | SOpen-market sale Common Stockindirect: By Trust | -120 | $4.00 | $480 | 759,849 | Dec 27, 2023 |
| Nov 29, 2023 | MIRA MIRA PHARMACEUTICALS, INC. | SOpen-market sale Common Stockindirect: By Trust | -3,700 | $3.98 | $15k | 756,149 | Dec 27, 2023 |
| Nov 30, 2023 | MIRA MIRA PHARMACEUTICALS, INC. | SOpen-market sale Common Stockindirect: By Trust | -2,421 | $3.77 | $9,136 | 753,728 | Dec 27, 2023 |
| Dec 4, 2023 | MIRA MIRA PHARMACEUTICALS, INC. | SOpen-market sale Common Stockindirect: By Trust | -30,666 | $3.98 | $122k | 723,062 | Dec 27, 2023 |
| Dec 6, 2023 | MIRA MIRA PHARMACEUTICALS, INC. | SOpen-market sale Common Stockindirect: By Trust | -13,866 | $2.95 | $41k | 709,196 | Dec 27, 2023 |
| Dec 7, 2023 | MIRA MIRA PHARMACEUTICALS, INC. | SOpen-market sale Common Stockindirect: By Trust | -16,667 | $1.89 | $32k | 692,529 | Dec 27, 2023 |
| Dec 8, 2023 | MIRA MIRA PHARMACEUTICALS, INC. | SOpen-market sale Common Stockindirect: By Trust | -9,527 | $1.61 | $15k | 683,002 | Dec 27, 2023 |
| Dec 11, 2023 | MIRA MIRA PHARMACEUTICALS, INC. | SOpen-market sale Common Stockindirect: By Trust | -23,002 | $1.55 | $36k | 660,000 | Dec 27, 2023 |
Questions about Brian Patrick McNulty
Answered from the filings on this page, as of the latest one.
Is Brian Patrick McNulty buying or selling?
Not in the last 12 months. Brian Patrick McNulty's latest open-market trade on SEC Form 4 was sold $392k of MIRA on Aug 28, 2024.
How did Brian Patrick McNulty's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Brian Patrick McNulty has 0.
Where does Brian Patrick McNulty file Form 4?
Brian Patrick McNulty has filed Form 4 at MIRA (MIRA PHARMACEUTICALS, INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.